Markets
BSE See NSE See 73,852.94
114.49 (0.16%)
 

News Details

Hon'ble Health Minister Dr. C. Vijaya Baskar Inaugurates the First-of-its-kind 'BONDS' Centre at SIMS Hospital, Vadapalani

SIMS Hospital (SRM Institutes for Medical Science) one of the leading quaternary care super specialty hospital in Chennai, announced today, the launch of BONDS, (BOtulinum ToxiN in Dystonia Spasticity), a first of its kind centre in Chennai with focused approach to the treatment of movement disorders like Dystonia and Spasticity (also for Stroke Rehabilitation) using Botulinum Toxin injection at its Vadapalani facility in Chennai.

Dr. C Vijaya Baskar, Hon;ble Minister for Health Family Welfare, Govt. of Tamil Nadu Inaugurates BONDS; Centre of Excellence, a first-of-its-kindcenter dedicated to Dystonia Spasticity movement disorders at SIMS Hospital, Vadapalani on 29th Oct. 2020

From Left to Right

  • Dr. Raju Sivasamy, Vice President, SIMS Hospital

  • Dr. U. Meenakshisundaram, Director, Neurology, SIMS Hospital

  • Dr. C. Vijay Baskar, Honble Minister for Health Family Welfare, Govt. of Tamil Nadu

  • Shri. Ravi Pachamuthu, Chairman, SRM Group

  • Dr. K.R. Suresh Bapu, Director, Neurosurgery, SIMS Hospital

Inaugurated by Dr. C Vijaya Baskar- Hon. Minister for Health Family Welfare, Govt. of Tamil Nadu in the presence of Shri. Ravi Pachamuthu SRM Group, and other dignitaries, the Center of excellence prides of a state-of-the-art facility, complete with a vibrant and skilled team of doctors to handle neurological emergencies in addition to serving chronic patients. The Center is well equipped to offer wide spectrum of services to treat patients affected by various movement disorders including stroke, dystonia, spasticity and neuromuscular ailments.

Expressing his delight about the launch, Shri. Ravi Pachamoothoo, Chairman, SRM Group, said, SIMS has always been a proponent of evidence based clinical innovations. BONDS; Clinic marks yet another milestone in this journey and I congratulate Dr. Meenakshisundarm and his team for setting-up this center of excellence, which I am sure, will bring in a significant relief to the people with movement disorders.

With such finest clinical talents and resources available in-house, who are always ready to adopt and embrace the latest and highly advanced medical practices, both, effectively and efficiently, we at SIMS will continue to deliver high rates of successful clinical treatments for our patients, he added.

An equally elated, Dr. U. Meenakshisundaram, the Director of the Neurology Department at SIMS Hospital, who is also the present Secretary of the Movement Disorders Society of India and an Executive Committee member of the Indian Academy of Neurology, said, Clinical research findings have revealed that over last few years the use of Botulinum toxin has shown great results in the treatment of movement disorders and when combined with a proper physiotherapy regimen, people with these conditions recover faster and return to a near-normal life much quickly. Also, administering Botulinum Toxin Injection is a skilled procedure and is done by skilled set of experienced practitioners, complete with progressive monitoring on the patient improvement.

The treatment is done as an outpatient procedure and spans between 3 to 6 months duration with minimal side effects caused due to the weakening of muscles, which are mostly reversible depending on the patient medical condition and their response to the treatment,Dr. Meenakshisundaram added.

A case reference of a successful treatment

An Indian student in his 20s developed spastic weakness in his left hand and leg due to an infarct in the brain resulting from sudden pulmonary thromboembolism during a skiing accident in South Korea. He was initially treated at a hospital in Japan; after which he was referred to SIMS Hospital for further management of his spasticity. He was evaluated and injected with Botulinum toxin and two weeks later, he had significant relief from the spasticity, thus substantially reducing his disability.

About Botulinum

Botulinum toxin is like the villain who turned hero. It is produced by the bacteria Clostridium Botulinum. Ingestion of this toxin can lead to the deadly disease called botulism. It basically paralyses muscles (and some secretory activity). Science has made use of this feature and has brought in the concept of controlled paralysis, wherein only the abnormally excessive unwanted activity is reduced while retaining and supporting meaningful muscle activity.

Although there are many types of toxins produced, only types A and B are used in medical practice (In India, we have only type A available as of now). Neurons or nerve cells communicate with one other and with muscle and other organs through chemicals called neurotransmitters. Botulinum toxin primarily acts by blocking the release of the neurotransmitter acetylcholine. By this way, it helps in relieving unwanted, excessive muscle contraction. In this way, it has been applied to a wide variety of conditions including for cosmetic purposes. In neurology, it is primarily used in dystonias and spasticity apart from conditions such as chronic migraine, hyperhidrosis (increased sweating) and sialorrhea (increased drooling of saliva).

About Dystonia

Dystonias are a group of disorders which cause abnormal posturing or movements of a body part(s) because some muscle groups go into abnormal, asynchronous contraction. They cause significant disability and discomfort to the sufferers and are in general not very responsive to treatment with oral medications. A common type is the task-specific dystonia where it occurs only with specific tasks such as writing (writer cramps), playing musical instruments (such as Piano, Guitar, Mridangam etc.) playing golf or billiards, or counting currency notes.

About Spasticity

Spasticity is abnormal stiffness that happens in diseases of the brain and/or spinal cord. The stiffness can be pronounced and can cause considerable difficulty in activities of daily living. It can happen in children due to cerebral palsy and other disorders. A common setting is post-stroke spasticity wherein the paralysed limb(s) become stiff over time and cause impediments to further recovery.

About SIMS Hospital

SIMS Hospital (SRM Institutes for Medical Science) is one of the leading quaternary care super speciality hospital in Chennai. This 345-bed hospital offers comprehensive healthcare experience across a wide range of specialities, including multi-organ transplant services. The hospital houses 15 modular OTs, 3 state-of-the-art Cath labs (including 1 Bi-plane Cath lab), advanced ICUs with Hepa filters and innovative medical technologies, all under one roof. With the finest combination of experience, expertise, cutting-edge technology and well-coordinated multi-speciality Quaternary care facilities and patient-centric team-work, SIMS Hospital Chennai is committed to deliver services of international standards. SIMS Hospital offers holistic health care that includes prevention, prophylactic treatment and care, rehabilitation and lifestyle health education and guidance to patients, their families and clients. At SIMS, every step is aimed at ensuring excellence in patient care.

 

News List

 
3/30/2023 10:50:11 AM

Tresorfx, a leading global investment firm, is excited to announce the launch of its new and revolutionary automated copy trading service for investors. This new service aims to help retail investors automatically copy the Tresorfx master accoun...


3/30/2023 9:38:34 AM

Planify has recently opened its doors to bring onboard the rapidly emerging star in the Crude Coal tar Industry, VCI Chemical Industries. Planify is the biggest platform that connects entrepreneurs with investors for hassle-fr...


3/29/2023 3:58:52 PM

KlarifyLife, an initiative by HDFC Life, has launched Term Guide;, a customised solution that aims to simplify the decision-making process for customers while purchasing term insurance. It also works as an aid for customers who are in the proces...


3/29/2023 2:55:52 PM

TechGig, India largest developer community, announced a strategic partnership with LinkedIn, the worlds largest professional network firm, for better engagement and outreach with the community. The idea behind the collaboration is to leverage Li...


3/29/2023 12:20:49 PM

FlyBlade India (BLADE India), a joint venture between Hunch Ventures and Blade Air Mobility, Inc. (NASDAQ: BLDE), and Jaunt Air Mobility (Jaunt), an AIRO Group company, announced today a strategic partnership to launch electric vertical take-off...


12345678910...